| Aetna | Burosumab-twza (Crysvita) | 2025-01-17 |
| Medicare FCSO | Billing and Coding: Cervical Fusion (59674) | 2025-01-17 |
| Medicare NGS | Billing and Coding: Cervical Fusion (59632) | 2025-01-17 |
| Medicare Novitas | Billing and Coding: Cervical Fusion (59668) | 2025-01-17 |
| Medicare Palmetto | Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (58700) | 2025-01-17 |
| Aetna | Transfusion | 2025-01-16 |
| Aetna | Trabectedin (Yondelis) | 2025-01-16 |
| Aetna | Signal-Averaged Electrocardiography (SAECG) and Artificial Intelligence Algorithmic Electrocardiogram for Cardiovascular-Related Diseases | 2025-01-15 |
| BCBS Florida Coverage Guidelines | Asfotase alfa (Strensiq®) (09-J2000-58) | 2025-01-15 |
| BCBS Florida Coverage Guidelines | Burosumab-twza (Crysvita®) (09-J2000-99) | 2025-01-15 |